Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07428967

AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function

AtrioVentricular Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function - a Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
86 (estimated)
Sponsor
St. Josefs-Hospital Wiesbaden GmbH · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

AVA CONDUCT is a prospective, multicenter, randomized study with single blinding, comparing left bundle branch area (LBBA) pacing with right ventricular (RV) pacing following AV node ablation in terms of clinical, functional, and electrophysiological outcomes. The primary hypothesis is that pacing-induced cardiomyopathy, defined as a decrease in LVEF by 10% or more from baseline to an absolute value below 50%, occurs significantly more frequently in patients receiving RV pacing compared with LBBA pacing. Secondarily, LBBA pacing is expected to maintain comparable procedural safety while providing better cardiac function, resulting in improved quality of life and functional capacity compared with conventional RV pacing.

Conditions

Interventions

TypeNameDescription
PROCEDURERV pacingRV apical pacemaker implantation prior to AV node ablation
PROCEDURELBBA pacingLBBA pacemaker implantation prior to AV node ablation

Timeline

Start date
2026-02-01
Primary completion
2028-12-31
Completion
2029-12-31
First posted
2026-02-24
Last updated
2026-02-24

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT07428967. Inclusion in this directory is not an endorsement.